Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Wyeth-Ayerst International

Division of Pfizer Inc.

Latest From Wyeth-Ayerst International

Arena Finds Antidote For Belviq’s Theoretical Risk Of Valvulopathy In Mechanistic Studies

Additional preclinical studies provided FDA with reassurance during a second-cycle review that lorcaserin was unlikely to trigger the valvular heart disease associated with dexfenfluramine and fenfluramine.

BioPharmaceutical North America

Institute for Diagnostic Research

Institute for Diagnostic Research, a privately-held company, is focused on customized assay development for pharmaceutical and diagnostic companies.
BioPharmaceutical Platform Technologies

The Tantalizing Market for Stroke Devices

A potentially enormous market without therapeutic options is attracting a lot of new technology developesr and venture capital to stroke. But the opportunity for clot-busting approaches is limited and getting enough patients for clinical trials is tough. In a market full of unknowns, one thing is certain: the ultimate goal of any stroke therapy is to avoid neurological deficit.
Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • Bernard Poussot, Pres.
    Robert Power, VP, Global Mktg.
  • Contact Info
  • Wyeth-Ayerst International
    Phone: (610) 688-4400
    150 Radnor-Chester Road
    St. Davids, PA 19087